Clinical Trials Logo

Clinical Trial Summary

The goal of this prospective study is to evaluate the feasibility of the Core Biopsy Needle with reverse bevel (Procore TM) in diagnosing autoimmune pancretitis


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01774513
Study type Interventional
Source Technische Universität München
Contact Stefan von Delius, MD
Email stefan_ruckert@yahoo.de
Status Recruiting
Phase N/A
Start date January 2013

See also
  Status Clinical Trial Phase
Recruiting NCT03753815 - Diagnostic Yield of FNA Needle and FNB Needle for Autoimmune Pancreatitis N/A
Recruiting NCT02797665 - Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids N/A
Recruiting NCT04834505 - To Differentiate Focal Autoimmune Pancreatitis From Pancreatic Cancer by Endoscopic Ultrasound
Recruiting NCT04397731 - Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune Pancreatitis
Not yet recruiting NCT06358001 - EchoTip AcuCore Post-Market Clinical Study
Completed NCT05476978 - Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
Recruiting NCT06369909 - Study on AI-assisted Multimodal Diagnosis System of Autoimmune Pancreatitis
Completed NCT03241797 - Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis N/A
Completed NCT05171517 - Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
Withdrawn NCT01845467 - Efficacy of Secretin MRCP in the Diagnosis and Follow up of Auto Immune Pancreatitis
Completed NCT05565066 - A Real-world Comparison of FNB and FNA in IHC-required Lesions.
Withdrawn NCT02766842 - Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) Phase 2
Completed NCT02705638 - Treatment of IgG4-Related Disease With Revlimid and Rituximab Phase 1
Completed NCT01584388 - Rituximab in IgG4-related Disease: A Phase 1-2 Trial Phase 1/Phase 2
Completed NCT00588367 - CT Pancreas Perfusion N/A